Wenwei Lin

Prof. Wenwei Lin


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2016 in Organic Letters
Verified
Journal Article
Closed access
CLChia-Jui Lee
Chia-Jui Lee
TCTzu-Hsiu Chang
Tzu-Hsiu Chang
JYJhen-Kuei Yu
Jhen-Kuei Yu
GRGanapuram Madhusudhan Reddy
Ganapuram Madhusudhan Reddy
MHMing-Yu Hsiao
Ming-Yu Hsiao
WLWenwei Lin
Wenwei Lin

6 May 2013 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
UDUtpal Das
Utpal Das
YCYi-Ru Chen
Yi-Ru Chen
YTYi‐Ling Tsai
Yi‐Ling Tsai
WLWenwei Lin
Wenwei Lin

1 January 2018 in Tetrahedron Letters
Verified
Journal Article
Closed access
PKPraneeth Karanam
Praneeth Karanam
GRGanapuram Madhusudhan Reddy
Ganapuram Madhusudhan Reddy
SKSrinivasa Rao Koppolu
Srinivasa Rao Koppolu
WLWenwei Lin
Wenwei Lin

14 September 2018 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
PDF file
SLShin‐Ying Lee
Shin‐Ying Lee
YCYa-Jen Chiu
Ya-Jen Chiu
SYShu‐Mei Yang
Shu‐Mei Yang
CCChiung‐Mei Chen
Chiung‐Mei Chen
CHChin‐Chang Huang
Chin‐Chang Huang
KCKuo-Hsuan Chang
Kuo-Hsuan Chang
Background: Aggregation of misfolded amyloid β (Aβ) in senile plaques causes oxidative stress and neuronal death in Alzheimer's disease (AD). Compounds possessing antiaggregation and antioxidant properties are promising candidate compounds for AD treatment.Methods: We examined the potential of synthetic derivatives of licochalcone A and coumarin for inhibiting Aβ aggregation, scavenging reactive oxygen species (ROS), and providing neuroprotection by using biochemical assays and Tet‐On Aβ‐GFP 293/SH‐SY5Y cell models for AD.Results: Among test compounds, LM‐031, a novel chalcone‐coumarin hybrid, inhibited Aβ aggregation and scavenged free oxygen radicals. LM‐031 markedly reduced Aβ misfolding and ROS as well as promoted neurite outgrowth and inhibited acetylcholinesterase in Tet‐On Aβ‐GFP 293/SH‐SY5Y cells. Mechanistic studies showed upregulation of the HSPB1 chaperone, NRF2/NQO1/GCLC pathway, and CREB/BDNF/BCL2 pathway. Decreased neurite outgrowth upon the induction of Aβ‐GFP was rescued by LM‐031, which was counteracted by knockdown of HSPB1, NRF2, or CREB.Conclusion: Taken together, these findings demonstrate that LM‐031 exhibited antiaggregation, antioxidant, and neuroprotective effects against Aβ toxicity by enhancing HSPB1 and the NRF2‐related antioxidant pathway as well as by activating the CREB‐dependent survival and antiapoptosis pathway. These results imply that LM‐031 may be a new therapeutic compound for AD.

17 October 2011 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
YJYeong-Jiunn Jang
Yeong-Jiunn Jang
SSSiang-En Syu
Siang-En Syu
YCYu-Jhang Chen
Yu-Jhang Chen
MYMei-Chun Yang
Mei-Chun Yang
WLWenwei Lin
Wenwei Lin
A new and general strategy for highly functional furo[3,4-c]coumarins and related furyl coumarin derivatives has been developed, which is based on an extraordinarily facile intramolecular Wittig reaction, starting from α,β-unsaturated ketones, tributylphosphine, and acyl chlorides. The phosphorus ylides were proposed to be the key intermediates for constructing the crucial furan ring, leading to a wide variety of substituted furyl coumarins in one step.

22 October 2012 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
UDUtpal Das
Utpal Das
YTYi-Ling Tsai
Yi-Ling Tsai
WLWenwei Lin
Wenwei Lin
An organocatalytic asymmetric synthesis of spironitrocyclopropanes has been demonstrated starting from 2-arylidene-1,3-indandiones and bromonitroalkanes catalyzed by a cinchona-derived bifunctional organocatalyst. The products were obtained with excellent enantioselectivities, diastereoselectivities and with good yields.